{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:35:05Z","timestamp":1790411705776,"version":"4.1.0"},"reference-count":266,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,1]]},"abstract":"<jats:p>OBJECTIVE. This was a systematic evidence review for the US Preventive Services Task Force, intended to synthesize the published evidence regarding the effectiveness of selecting, testing, and managing children and adolescents with dyslipidemia in the course of routine primary care.<\/jats:p>\n                  <jats:p>METHODS. Literature searches were performed to identify published articles that addressed 10 key questions. The review focused on screening relevant to primary care of children without previously identified dyslipidemias, but included treatment trials of children with dyslipidemia because some drugs have only been tested in that population.<\/jats:p>\n                  <jats:p>RESULTS. Normal values for lipids for children and adolescents are defined according to population levels (percentiles). Age, gender, and racial differences and temporal trends may alter these statistical cut points. Approximately 40% to 55% of children with elevated total cholesterol and low-density lipoprotein levels will continue to have elevated lipid levels on follow-up. Current screening recommendations based on family history will fail to detect substantial numbers (30%\u201360%) of children with elevated lipid levels. Drug treatment for dyslipidemia in children has been studied and shown to be effective only for suspected or proven familial monogenic dyslipidemias. Intensive dietary counseling and follow-up can result in improvements in lipid levels, but these results have not been sustained after the cessation of the intervention. The few trials of exercise are of fair-to-poor quality and show little or no improvements in lipid levels for children without monogenic dyslipidemias. Although reported adverse effects were not serious, studies were generally small and not of sufficient duration to determine long-term effects of either short or extended use.<\/jats:p>\n                  <jats:p>CONCLUSIONS. Several key issues about screening and treatment of dyslipidemia in children and adolescents could not be addressed because of lack of studies, including effectiveness of screening on adult coronary heart disease or lipid outcomes, optimal ages and intervals for screening children, or effects of treatment of childhood lipid levels on adult coronary heart disease outcomes.<\/jats:p>","DOI":"10.1542\/peds.2006-1801","type":"journal-article","created":{"date-parts":[[2007,7,2]],"date-time":"2007-07-02T12:35:25Z","timestamp":1183379725000},"page":"e189-e214","source":"Crossref","is-referenced-by-count":143,"title":["Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force"],"prefix":"10.1542","volume":"120","author":[{"given":"Elizabeth M.","family":"Haney","sequence":"first","affiliation":[{"name":"Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology"},{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie Hoyt","family":"Huffman","sequence":"additional","affiliation":[{"name":"Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bougatsos","sequence":"additional","affiliation":[{"name":"Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Freeman","sequence":"additional","affiliation":[{"name":"Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Steiner","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi D.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology"},{"name":"Department of Medicine"},{"name":"Women and Children's Health Research Center, Providence Health System, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,7,1]]},"reference":[{"key":"2021120901591128900_R1","unstructured":"Ahmed SM, Clasen ME, Donnelly JE. Management of dyslipidemia in adults. Am Fam Physician.\u20081998;57:2192\u20132204"},{"key":"2021120901591128900_R2","unstructured":"Newman Dorland WA, ed. Dorland's Illustrated Medical Dictionary. 29th ed. Philadelphia, PA: WB Saunders; 2000"},{"key":"2021120901591128900_R3","unstructured":"Centers for Disease Control and Prevention. Mortality from coronary heart disease and acute myocardial infarction: United States, 1998. MMWR Morb Mortal Wkly Rep.\u20082001;50:90\u201393"},{"key":"2021120901591128900_R4","unstructured":"Schrott HG, Bucher KA, Clarke WR, Lauer RM. The Muscatine Hyperlipidemia Family Study program. Prog Clin Biol Res.\u20081979;32:619\u2013646"},{"key":"2021120901591128900_R5","doi-asserted-by":"crossref","unstructured":"Bao W, Srinivasan SR, Valdez R, Greenlund KJ, Wattigney WA, Berenson GS. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. JAMA.\u20081997;278:1749\u20131754","DOI":"10.1001\/jama.278.21.1749"},{"key":"2021120901591128900_R6","doi-asserted-by":"crossref","unstructured":"Kwiterovich PO Jr. Prevention of coronary disease starting in childhood: what risk factors should be identified and treated?Coron Artery Dis.\u20081993;4:611\u2013630","DOI":"10.1097\/00019501-199307000-00006"},{"key":"2021120901591128900_R7","doi-asserted-by":"crossref","unstructured":"Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA.\u20081990;264:3018\u20133024","DOI":"10.1001\/jama.264.23.3018"},{"key":"2021120901591128900_R8","doi-asserted-by":"crossref","unstructured":"Newman WP 3rd, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med.\u20081986;314:138\u2013144","DOI":"10.1056\/NEJM198601163140302"},{"key":"2021120901591128900_R9","doi-asserted-by":"crossref","unstructured":"Freedman DS, Newman WP 3rd, Tracy RE, et al. Black-white differences in aortic fatty streaks in adolescence and early adulthood: the Bogalusa Heart Study. Circulation.\u20081988;77:856\u2013864","DOI":"10.1161\/01.CIR.77.4.856"},{"key":"2021120901591128900_R10","doi-asserted-by":"crossref","unstructured":"Berenson GS, Wattigney WA, Tracy RE, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol.\u20081992;70:851\u2013858","DOI":"10.1016\/0002-9149(92)90726-F"},{"key":"2021120901591128900_R11","doi-asserted-by":"crossref","unstructured":"Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med.\u20081998;338:1650\u20131656","DOI":"10.1056\/NEJM199806043382302"},{"key":"2021120901591128900_R12","unstructured":"Strong JP, Zieske AW, Malcom GT. Lipoproteins and atherosclerosis in children: an early marriage?Nutr Metab Cardiovasc Dis.\u20082001;11(suppl 5):16\u201322"},{"key":"2021120901591128900_R13","doi-asserted-by":"crossref","unstructured":"Eyre H, Kahn R, Robertson RM, et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation.\u20082004;109:3244\u20133255","DOI":"10.1161\/01.CIR.0000133321.00456.00"},{"key":"2021120901591128900_R14","doi-asserted-by":"crossref","unstructured":"Kavey REW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American heart association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr.\u20082003;142:368\u2013372","DOI":"10.1067\/mpd.2003.205"},{"key":"2021120901591128900_R15","doi-asserted-by":"crossref","unstructured":"Williams CL, Hayman LL, Daniels SR, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association [published correction appears in Circulation. 2002;106:1178]. Circulation.\u20082002;106:143\u2013160","DOI":"10.1161\/01.CIR.0000019555.61092.9E"},{"key":"2021120901591128900_R16","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Nutrition. Cholesterol in childhood. Pediatrics.\u20081998;101:141\u2013147","DOI":"10.1542\/peds.101.1.141"},{"key":"2021120901591128900_R17","unstructured":"American Heart Association. Step I, Step II and TLC diets. Available at: www.americanheart.org\/presenter.jhtml?identifier=4764. Accessed April 29, 2005"},{"key":"2021120901591128900_R18","doi-asserted-by":"crossref","unstructured":"Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA.\u20082004;292:331\u2013337","DOI":"10.1001\/jama.292.3.331"},{"key":"2021120901591128900_R19","doi-asserted-by":"crossref","unstructured":"Clauss SB, Holmes KW, Hopkins P, et al. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics.\u20082005;116:682\u2013688","DOI":"10.1542\/peds.2004-2090"},{"key":"2021120901591128900_R20","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics.\u20081992;89(3 pt 2):525\u2013584","DOI":"10.1542\/peds.89.3.495"},{"key":"2021120901591128900_R21","doi-asserted-by":"crossref","unstructured":"Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med.\u20082001;20(3 suppl):21\u201335.","DOI":"10.1016\/S0749-3797(01)00261-6"},{"key":"2021120901591128900_R22","unstructured":"Haney EM, Huffman LH, Bougatsos CM, et al. Screening for Dyslipidemia in Children and Adolescents: Systematic Evidence Synthesis. Rockville, MD: Agency for Healthcare Research and Quality; 2006. Available at: www.ahrq.gov\/clinic\/uspstf\/uspstopics.htm. Accessed April 27, 2007"},{"key":"2021120901591128900_R23","unstructured":"National Heart Lung and Blood Institute. Cardiovascular Profile of 15,000 Children of School Age in Three Communities 1971\u20131975. Bethesda, MD: US Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health; 1978"},{"key":"2021120901591128900_R24","unstructured":"Berenson GS. Cardiovascular Risk Factors in Children. New York, NY: Oxford University Press; 1980"},{"key":"2021120901591128900_R25","unstructured":"National Center for Health Statistics. Serum Cholesterol Levels of Persons 4\u201374 Years of Age by Socioeconomic Characteristics: United States, 1971\u201374. Hyattsville, MD: US Department of Health Education and Welfare, Public Health Service, National Center for Health Statistics; 1980"},{"key":"2021120901591128900_R26","unstructured":"Baker SG, Joffe BI, Mendelsohn D, Seftel HC. Treatment of homozygous familial hypercholesterolaemia with probucol. S Afr Med J.\u20081982;62:7\u201311"},{"key":"2021120901591128900_R27","unstructured":"Lipid Research Clinics Program. The Lipid Research Clinics Population Studies Data Book. Vol 1. Bethesda, MD: National Institutes of Health, Lipid Metabolism Branch, Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute; 1980"},{"key":"2021120901591128900_R28","doi-asserted-by":"crossref","unstructured":"Hickman TB, Briefel RR, Carrol MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4\u201319 years: data from the third National Health and Nutrition Examination Survey. Prev Med.\u20081998;27:879\u2013890","DOI":"10.1006\/pmed.1998.0376"},{"key":"2021120901591128900_R29","doi-asserted-by":"crossref","unstructured":"Labarthe DR, Dai S, Fulton JE. Cholesterol screening in children: insights from Project HeartBeat! and NHANES III. Prog Pediatr Cardiol.\u20082003;17:169\u2013178","DOI":"10.1016\/S1058-9813(03)00054-7"},{"key":"2021120901591128900_R30","doi-asserted-by":"crossref","unstructured":"Kwiterovich PO Jr, Heiss G, Johnson N, Chase GA, Tamir I, Rifkind B. Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample. Am J Epidemiol.\u20081982;115:192\u2013204","DOI":"10.1093\/oxfordjournals.aje.a113291"},{"key":"2021120901591128900_R31","doi-asserted-by":"crossref","unstructured":"Dennison BA, Kikuchi DA, Srinivasan SR, Webber LS, Berenson GS. Serum total cholesterol screening for the detection of elevated low-density lipoprotein in children and adolescents: the Bogalusa Heart Study. Pediatrics.\u20081990;85:472\u2013479","DOI":"10.1542\/peds.85.4.472"},{"key":"2021120901591128900_R32","doi-asserted-by":"crossref","unstructured":"Rifai N, Neufeld E, Ahlstrom P, Rimm E, D'Angelo L, Hicks JM. Failure of current guidelines for cholesterol screening in urban African-American adolescents. Pediatrics.\u20081996;98:383\u2013388.","DOI":"10.1542\/peds.98.3.383"},{"key":"2021120901591128900_R33","doi-asserted-by":"crossref","unstructured":"Shea S, Basch CE, Irigoyen M, et al. Failure of family history to predict high blood cholesterol among Hispanic preschool children. Prev Med.\u20081990;19:443\u2013455","DOI":"10.1016\/0091-7435(90)90042-I"},{"key":"2021120901591128900_R34","doi-asserted-by":"crossref","unstructured":"Gillman MW, Cupples LA, Moore LL, Ellison RC. Impact of within-person variability on identifying children with hypercholesterolemia: Framingham Children's Study. J Pediatr.\u20081992;121:342\u2013347","DOI":"10.1016\/S0022-3476(05)81785-8"},{"key":"2021120901591128900_R35","doi-asserted-by":"crossref","unstructured":"Harris N, Neufeld EJ, Newburger JW, et al. Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. Clin Chem.\u20081996;42:1182\u20131188.","DOI":"10.1093\/clinchem\/42.8.1182"},{"key":"2021120901591128900_R36","doi-asserted-by":"crossref","unstructured":"Ticho BS, Neufeld EJ, Newburger JW, Harris N, Baker A, Rifai N. Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients. Arch Pediatr Adolesc Med.\u20081998;152:787\u2013791","DOI":"10.1001\/archpedi.152.8.787"},{"key":"2021120901591128900_R37","doi-asserted-by":"crossref","unstructured":"Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study. Arch Intern Med.\u20081996;156:1315\u20131320","DOI":"10.1001\/archinte.156.12.1315"},{"key":"2021120901591128900_R38","doi-asserted-by":"crossref","unstructured":"Freedman DS, Shear CL, Srinivasan SR, Webber LS, Berenson GS. Tracking of serum lipids and lipoproteins in children over an 8-year period: the Bogalusa Heart Study. Prev Med.\u20081985;14:203\u2013216","DOI":"10.1016\/0091-7435(85)90036-2"},{"key":"2021120901591128900_R39","doi-asserted-by":"crossref","unstructured":"Berenson GS, Srinivasan SR, Frerichs RR, Webber LS. Serum high density lipoprotein and its relationship to cardiovascular disease risk factor variables in children: the Bogalusa heart study. Lipids.\u20081979;14:91\u201398","DOI":"10.1007\/BF02533576"},{"key":"2021120901591128900_R40","doi-asserted-by":"crossref","unstructured":"Kelder SH, Osganian SK, Feldman HA, et al. Tracking of physical and physiological risk variables among ethnic subgroups from third to eighth grade: the Child and Adolescent Trial for Cardiovascular Health cohort study. Prev Med.\u20082002;34:324\u2013333","DOI":"10.1006\/pmed.2001.0990"},{"key":"2021120901591128900_R41","doi-asserted-by":"crossref","unstructured":"Clarke WR, Schrott HG, Leaverton PE, Connor WE, Lauer RM. Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation.\u20081978;58:626\u2013634","DOI":"10.1161\/01.CIR.58.4.626"},{"key":"2021120901591128900_R42","unstructured":"Lauer RM, Lee J, Clarke WR. Predicting adult cholesterol levels from measurements in childhood and adolescence: the Muscatine Study. Bull N Y Acad Med.\u20081989;65:1127\u20131142"},{"key":"2021120901591128900_R43","doi-asserted-by":"crossref","unstructured":"Stuhldreher WL, Orchard TJ, Donahue RP, Kuller LH, Gloninger MF, Drash AL. Cholesterol screening in childhood: sixteen-year Beaver County Lipid Study experience. J Pediatr.\u20081991;119:551\u2013556","DOI":"10.1016\/S0022-3476(05)82403-5"},{"key":"2021120901591128900_R44","doi-asserted-by":"crossref","unstructured":"Namboodiri KK, Green PP, Walden C, et al. The Collaborative Lipid Research Clinics Program Family Study. II. Response rates, representativeness of the sample, and stability of lipid and lipoprotein levels. Am J Epidemiol.\u20081984;119:944\u2013958","DOI":"10.1093\/oxfordjournals.aje.a113816"},{"key":"2021120901591128900_R45","doi-asserted-by":"crossref","unstructured":"Laskarzewski P, Morrison JA, de Groot I, et al. Lipid and lipoprotein tracking in 108 children over a four-year period. Pediatrics.\u20081979;64:584\u2013591","DOI":"10.1542\/peds.64.5.584"},{"key":"2021120901591128900_R46","doi-asserted-by":"crossref","unstructured":"Guo S, Beckett L, Chumlea WC, Roche AF, Siervogel RM. Serial analysis of plasma lipids and lipoproteins from individuals 9\u201321 y of age. Am J Clin Nutr.\u20081993;58:61\u201367","DOI":"10.1093\/ajcn\/58.1.61"},{"key":"2021120901591128900_R47","doi-asserted-by":"crossref","unstructured":"Baumgartner RN, Guo S, Roche AF. Tracking of lipids and lipoproteins in adolescents from 12\u201322 years of age. The Fels longitudinal study. Ann N Y Acad Sci.\u20081991;623:406\u2013409","DOI":"10.1111\/j.1749-6632.1991.tb43750.x"},{"key":"2021120901591128900_R48","doi-asserted-by":"crossref","unstructured":"Twisk JW, Kemper HC, van Mechelen W, Post GB. Tracking of risk factors for coronary heart disease over a 14-year period: a comparison between lifestyle and biologic risk factors with data from the Amsterdam Growth and Health Study. Am J Epidemiol.\u20081997;145:888\u2013898","DOI":"10.1093\/oxfordjournals.aje.a009048"},{"key":"2021120901591128900_R49","doi-asserted-by":"crossref","unstructured":"Mohler B, Ackermann-Liebrich U, Steffen T, Staehelin HB. Cholesterol screening in childhood: results of a 9-year follow-up study in Swiss and Italian children in Switzerland. Soz Praventivmed.\u20081996;41:333\u2013340","DOI":"10.1007\/BF01324282"},{"key":"2021120901591128900_R50","doi-asserted-by":"crossref","unstructured":"Vobecky JS, David P, Vobecky J. Dietary habits in relation to tracking of cholesterol level in young adolescents: a nine-year follow-up. Ann Nutr Metab.\u20081988;32:312\u2013323.","DOI":"10.1159\/000177474"},{"key":"2021120901591128900_R51","doi-asserted-by":"crossref","unstructured":"Katzmarzyk PT, Perusse L, Malina RM, Bergeron J, Despres JP, Bouchard C. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Quebec Family Study. J Clin Epidemiol.\u20082001;54:190\u2013195","DOI":"10.1016\/S0895-4356(00)00315-2"},{"key":"2021120901591128900_R52","doi-asserted-by":"crossref","unstructured":"Kallio MJ, Salmenpera L, Siimes MA, Perheentupa J, Miettinen TA. Tracking of serum cholesterol and lipoprotein levels from the first year of life. Pediatrics.\u20081993;91:949\u2013954","DOI":"10.1542\/peds.91.5.949"},{"key":"2021120901591128900_R53","doi-asserted-by":"crossref","unstructured":"Bastida S, Sanchez-Muniz FJ, Cuena R, Perea S, Aragones A. High density lipoprotein-cholesterol changes in children with high cholesterol levels at birth. Eur J Pediatr.\u20082002;161:94\u201398","DOI":"10.1007\/s00431-001-0863-y"},{"key":"2021120901591128900_R54","doi-asserted-by":"crossref","unstructured":"Porkka KV, Viikari JS, Akerblom HK. Tracking of serum HDL-cholesterol and other lipids in children and adolescents: the Cardiovascular Risk in Young Finns Study. Prev Med.\u20081991;20:713\u2013724","DOI":"10.1016\/0091-7435(91)90066-D"},{"key":"2021120901591128900_R55","doi-asserted-by":"crossref","unstructured":"Porkka KV, Viikari JS, Taimela S, Dahl M, Akerblom HK. Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns study. Am J Epidemiol.\u20081994;140:1096\u20131110","DOI":"10.1093\/oxfordjournals.aje.a117210"},{"key":"2021120901591128900_R56","doi-asserted-by":"crossref","unstructured":"Fuentes RM, Notkola IL, Shemeikka S, Tuomilehto J, Nissinen A. Tracking of serum total cholesterol during childhood: an 8-year follow-up population-based family study in eastern Finland. Acta Paediatr.\u20082003;92:420\u2013424","DOI":"10.1111\/j.1651-2227.2003.tb00571.x"},{"key":"2021120901591128900_R57","doi-asserted-by":"crossref","unstructured":"Eisenmann JC, Welk GJ, Wickel EE, Blair SN; Aerobics Center Longitudinal Study. Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study. Am J Hum Biol.\u20082004;16:690\u2013696","DOI":"10.1002\/ajhb.20079"},{"key":"2021120901591128900_R58","doi-asserted-by":"crossref","unstructured":"Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med.\u20082002;23(suppl 1):S39\u2013S43","DOI":"10.1055\/s-2002-28460"},{"key":"2021120901591128900_R59","doi-asserted-by":"crossref","unstructured":"Orchard TJ, Donahue RP, Kuller LH, Hodge PN, Drash AL. Cholesterol screening in childhood: does it predict adult hypercholesterolemia? The Beaver County experience. J Pediatr.\u20081983;103:687\u2013691","DOI":"10.1016\/S0022-3476(83)80458-2"},{"key":"2021120901591128900_R60","unstructured":"Bell MM, Joseph S. Screening 1140 fifth graders for hypercholesterolemia: family history inadequate to predict results. J Am Board Fam Pract.\u20081990;3:259\u2013263"},{"key":"2021120901591128900_R61","doi-asserted-by":"crossref","unstructured":"Davidson DM, Van Camp J, Iftner CA, Landry SM, Bradley BJ, Wong ND. Family history fails to detect the majority of children with high capillary blood total cholesterol. J Sch Health.\u20081991;61:75\u201380","DOI":"10.1111\/j.1746-1561.1991.tb03241.x"},{"key":"2021120901591128900_R62","doi-asserted-by":"crossref","unstructured":"Diller PM, Huster GA, Leach AD, Laskarzewski PM, Sprecher DL. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents. J Pediatr.\u20081995;126:345\u2013352","DOI":"10.1016\/S0022-3476(95)70446-9"},{"key":"2021120901591128900_R63","doi-asserted-by":"crossref","unstructured":"Gagliano NJ, Emans SJ, Woods ER. Cholesterol screening in the adolescent. J Adolesc Health.\u20081993;14:104\u2013108","DOI":"10.1016\/1054-139X(93)90093-5"},{"key":"2021120901591128900_R64","doi-asserted-by":"crossref","unstructured":"Griffin TC, Christoffel KK, Binns HJ, McGuire PA. Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatric Practice Research Group. Pediatrics.\u20081989;84:365\u2013373","DOI":"10.1542\/peds.84.2.365"},{"key":"2021120901591128900_R65","doi-asserted-by":"crossref","unstructured":"Muhonen LE, Burns TL, Nelson RP, Lauer RM. Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study. Pediatrics.\u20081994;93:444\u2013451","DOI":"10.1542\/peds.93.3.444"},{"key":"2021120901591128900_R66","doi-asserted-by":"crossref","unstructured":"Primrose ED, Savage JM, Boreham CA, Cran GW, Strain JJ. Cholesterol screening and family history of vascular disease. Arch Dis Child.\u20081994;71:239\u2013242","DOI":"10.1136\/adc.71.3.239"},{"key":"2021120901591128900_R67","doi-asserted-by":"crossref","unstructured":"Resnicow K, Cross D, Lacosse J, Nichols P. Evaluation of a school-site cardiovascular risk factor screening intervention. Prev Med.\u20081993;22:838\u2013856","DOI":"10.1006\/pmed.1993.1076"},{"key":"2021120901591128900_R68","doi-asserted-by":"crossref","unstructured":"Sanchez Bayle M, Gonzalez Vergaz A, Garcia Cuartero B, Santos Tapia M, Gonzalez Requejo A. Is a parental history of coronary arterial disease in children as discriminating as their lipoprotein profile? Nino Jesus Group. Int J Cardiol.\u20081992;36:267\u2013271","DOI":"10.1016\/0167-5273(92)90295-E"},{"key":"2021120901591128900_R69","doi-asserted-by":"crossref","unstructured":"Steiner NJ, Neinstein LS, Pennbridge J. Hypercholesterolemia in adolescents: effectiveness of screening strategies based on selected risk factors. Pediatrics.\u20081991;88:269\u2013275","DOI":"10.1542\/peds.88.2.269"},{"key":"2021120901591128900_R70","unstructured":"Troxler RG, Park MK, Miller MA, Karnavas BA, Lee DH. Predictive value of family history in detecting hypercholesterolemia in predominantly Hispanic adolescents. Tex Med.\u20081991;87:75\u201379"},{"key":"2021120901591128900_R71","doi-asserted-by":"crossref","unstructured":"Dennison BA, Kikuchi DA, Srinivasan SR, Webber LS, Berenson GS. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children. J Pediatr.\u20081989;115:186\u2013194","DOI":"10.1016\/S0022-3476(89)80063-0"},{"key":"2021120901591128900_R72","doi-asserted-by":"crossref","unstructured":"O'Loughlin J, Lauzon B, Paradis G, et al. Usefulness of the American Academy of Pediatrics recommendations for identifying youths with hypercholesterolemia. Pediatrics.\u20082004;113:1723\u20131727","DOI":"10.1542\/peds.113.6.1723"},{"key":"2021120901591128900_R73","doi-asserted-by":"crossref","unstructured":"Wadowski SJ, Karp RJ, Murray-Bachmann R, Senft C. Family history of coronary artery disease and cholesterol: screening children in a disadvantaged inner-city population. Pediatrics.\u20081994;93:109\u2013113","DOI":"10.1542\/peds.93.1.109"},{"key":"2021120901591128900_R74","doi-asserted-by":"crossref","unstructured":"Washington RL, Harrigan L, Day M. Early experience in treating hyperlipidemia in children. Ann N Y Acad Sci.\u20081991;623:434","DOI":"10.1111\/j.1749-6632.1991.tb43760.x"},{"key":"2021120901591128900_R75","doi-asserted-by":"crossref","unstructured":"Lannon CM, Earp J. Parents\u2019 behavior and attitudes toward screening children for high serum cholesterol levels. Pediatrics.\u20081992;89(6 pt 2):1159\u20131163","DOI":"10.1542\/peds.89.6.1159"},{"key":"2021120901591128900_R76","doi-asserted-by":"crossref","unstructured":"Boulton TJ. The validity of screening for hypercholesterolaemia at different ages from 2 to 17 years. Aust N Z J Med.\u20081979;9:542\u2013546","DOI":"10.1111\/j.1445-5994.1979.tb03392.x"},{"key":"2021120901591128900_R77","unstructured":"Williams RR, Hunt SC, Barlow GK, et al. Prevention of familial cardiovascular disease by screening for family history and lipids in youths. Clin Chem.\u20081992;38(8B pt 2):1555\u20131560."},{"key":"2021120901591128900_R78","doi-asserted-by":"crossref","unstructured":"Andersen LB, Wedderkopp N, Hansen HS, Cooper AR, Froberg K. Biological cardiovascular risk factors cluster in Danish children and adolescents: the European Youth Heart Study. Prev Med.\u20082003;37:363\u2013367","DOI":"10.1016\/S0091-7435(03)00145-2"},{"key":"2021120901591128900_R79","doi-asserted-by":"crossref","unstructured":"Bergstro\u0308m E, Hernell O, Persson LA. Endurance running performance in relation to cardiovascular risk indicators in adolescents. Int J Sports Med.\u20081997;18:300\u2013307","DOI":"10.1055\/s-2007-972638"},{"key":"2021120901591128900_R80","doi-asserted-by":"crossref","unstructured":"Bonora E, Zenere M, Branzi P, et al. Influence of body fat and its regional localization on risk factors for atherosclerosis in young men. Am J Epidemiol.\u20081992;135:1271\u20131278","DOI":"10.1093\/oxfordjournals.aje.a116233"},{"key":"2021120901591128900_R81","unstructured":"Bonora E, Targher G, Branzi P, et al. Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution. Int J Obes Relat Metab Disord.\u20081996;20:28\u201336"},{"key":"2021120901591128900_R82","doi-asserted-by":"crossref","unstructured":"Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation.\u20082001;104:2815\u20132819","DOI":"10.1161\/hc4601.099486"},{"key":"2021120901591128900_R83","doi-asserted-by":"crossref","unstructured":"Demerath E, Muratova V, Spangler E, Li J, Minor VE, Neal WA. School-based obesity screening in rural Appalachia. Prev Med.\u20082003;37:553\u2013560","DOI":"10.1016\/j.ypmed.2003.09.013"},{"key":"2021120901591128900_R84","doi-asserted-by":"crossref","unstructured":"DeStefano F, Berg RL, Griese GG Jr. Determinants of serum lipid and lipoprotein concentrations in children. Epidemiology.\u20081995;6:446\u2013449","DOI":"10.1097\/00001648-199507000-00024"},{"key":"2021120901591128900_R85","doi-asserted-by":"crossref","unstructured":"Douglas MB, Birrer RB, Medidi S, Schlussel YR. Obese children should be screened for hypercholesterolemia. J Health Care Poor Underserved.\u20081996;7:24\u201335","DOI":"10.1353\/hpu.2010.0012"},{"key":"2021120901591128900_R86","doi-asserted-by":"crossref","unstructured":"Durant RH, Linder CW, Jay S, Harkness JW, Gray RG. The influence of a family history of CHD risk factors on serum lipoprotein levels in black children and adolescents. J Adolesc Health Care.\u20081982;3:75\u201381","DOI":"10.1016\/S0197-0070(82)80098-3"},{"key":"2021120901591128900_R87","doi-asserted-by":"crossref","unstructured":"Durant RH, Linder CW, Mahoney OM. Relationship between habitual physical activity and serum lipoprotein levels in white male adolescents. J Adolesc Health Care.\u20081983;4:235\u2013240","DOI":"10.1016\/S0197-0070(83)80003-5"},{"key":"2021120901591128900_R88","doi-asserted-by":"crossref","unstructured":"Durant RH, Baranowski T, Rhodes T, et al. Association among serum lipid and lipoprotein concentrations and physical activity, physical fitness, and body composition in young children. J Pediatr.\u20081993;123:185\u2013192","DOI":"10.1016\/S0022-3476(05)81687-7"},{"key":"2021120901591128900_R89","doi-asserted-by":"crossref","unstructured":"Dwyer T, Gibbons LE. The Australian Schools Health and Fitness Survey: physical fitness related to blood pressure but not lipoproteins. Circulation.\u20081994;89:1539\u20131544","DOI":"10.1161\/01.CIR.89.4.1539"},{"key":"2021120901591128900_R90","doi-asserted-by":"crossref","unstructured":"Eisenmann JC, Malina RM. Age-related changes in subcutaneous adipose tissue of adolescent distance runners and association with blood lipoproteins. Ann Hum Biol.\u20082002;29:389\u2013397","DOI":"10.1080\/03014460110092252"},{"key":"2021120901591128900_R91","doi-asserted-by":"crossref","unstructured":"Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics.\u20081999;103:1175\u20131182.","DOI":"10.1542\/peds.103.6.1175"},{"key":"2021120901591128900_R92","doi-asserted-by":"crossref","unstructured":"Fripp RR, Hodgson JL, Kwiterovich PO, Werner JC, Schuler HG, Whitman V. Aerobic capacity, obesity, and atherosclerotic risk factors in male adolescents. Pediatrics.\u20081985;75:813\u2013818","DOI":"10.1542\/peds.75.5.813"},{"key":"2021120901591128900_R93","doi-asserted-by":"crossref","unstructured":"Giovannini M, Bellu R, Ortisi MT, Incerti P, Riva E. Cholesterol and lipoprotein levels in Milanese children: relation to nutritional and familial factors. J Am Coll Nutr.\u20081992;11(suppl):28S\u201331S","DOI":"10.1080\/07315724.1992.10737980"},{"key":"2021120901591128900_R94","doi-asserted-by":"crossref","unstructured":"Glassman MS, Schwarz SM. Cholesterol screening in children: should obesity be a risk factor?J Am Coll Nutr.\u20081993;12:270\u2013273","DOI":"10.1080\/07315724.1993.10718309"},{"key":"2021120901591128900_R95","unstructured":"Howard JK, Bindler RM, Dimico GS, et al. Cardiovascular risk factors in children: a Bloomsday research report. J Pediatr Nurs.\u20081991;6:222\u2013229"},{"key":"2021120901591128900_R96","doi-asserted-by":"crossref","unstructured":"Ja\u0308rvisalo MJ, Jartti L, Nanto-Salonen K, et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation.\u20082001;104:2943\u20132947","DOI":"10.1161\/hc4901.100522"},{"key":"2021120901591128900_R97","doi-asserted-by":"crossref","unstructured":"Larsson B, Vaara I. Cholesterol screening of seven-year-old children: how to identify children at risk. Acta Paediatr.\u20081992;81:315\u2013318","DOI":"10.1111\/j.1651-2227.1992.tb12233.x"},{"key":"2021120901591128900_R98","doi-asserted-by":"crossref","unstructured":"Kwiterovich PO Jr, Barton BA, McMahon RP, et al. Effects of diet and sexual maturation on low-density lipoprotein cholesterol during puberty: the Dietary Intervention Study in Children (DISC). Circulation.\u20081997;96:2526\u20132533","DOI":"10.1161\/01.CIR.96.8.2526"},{"key":"2021120901591128900_R99","doi-asserted-by":"crossref","unstructured":"Ma\u0301cek M, Bell D, Rutenfranz J, et al. A comparison of coronary risk factors in groups of trained and untrained adolescents. Eur J Appl Physiol Occup Physiol.\u20081989;58:577\u2013582","DOI":"10.1007\/BF00418502"},{"key":"2021120901591128900_R100","doi-asserted-by":"crossref","unstructured":"Marti B, Vartiainen E. Relation between leisure time exercise and cardiovascular risk factors among 15-year-olds in eastern Finland. J Epidemiol Community Health.\u20081989;43:228\u2013233","DOI":"10.1136\/jech.43.3.228"},{"key":"2021120901591128900_R101","doi-asserted-by":"crossref","unstructured":"Raitakari OT, Taimela S, Porkka KV, Viikari JS. Effect of leisure-time physical activity change on high-density lipoprotein cholesterol in adolescents and young adults. Ann Med.\u20081996;28:259\u2013263","DOI":"10.3109\/07853899609033128"},{"key":"2021120901591128900_R102","unstructured":"Resnicow K, Futterman R, Vaughan RD. Body mass index as a predictor of systolic blood pressure in a multiracial sample of US schoolchildren. Ethn Dis.\u20081993;3:351\u2013361"},{"key":"2021120901591128900_R103","doi-asserted-by":"crossref","unstructured":"Ribeiro JC, Guerra S, Oliveira J, et al. Physical activity and biological risk factors clustering in pediatric population. Prev Med.\u20082004;39:596\u2013601","DOI":"10.1016\/j.ypmed.2004.02.023"},{"key":"2021120901591128900_R104","doi-asserted-by":"crossref","unstructured":"Shear CL. The relationship between parental history of vascular disease and cardiovascular disease risk factors in children: the Bogalusa Heart Study. Am J Epidemiol.\u20081985;122:762\u2013771","DOI":"10.1093\/oxfordjournals.aje.a114159"},{"key":"2021120901591128900_R105","doi-asserted-by":"crossref","unstructured":"Simon JA, Morrison JA, Similo SL, McMahon RP, Schreiber GB. Correlates of high-density lipoprotein cholesterol in black girls and white girls: the NHLBI Growth and Health Study. Am J Public Health.\u20081995;85:1698\u20131702","DOI":"10.2105\/AJPH.85.12.1698"},{"key":"2021120901591128900_R106","doi-asserted-by":"crossref","unstructured":"Suter E, Hawes MR. Relationship of physical activity, body fat, diet, and blood lipid profile in youths 10\u201315 yr. Med Sci Sports Exerc.\u20081993;25:748\u2013754","DOI":"10.1249\/00005768-199306000-00016"},{"key":"2021120901591128900_R107","doi-asserted-by":"crossref","unstructured":"Thorland WG, Gilliam TB. Comparison of serum lipids between habitually high and low active pre-adolescent males. Med Sci Sports Exerc.\u20081981;13:316\u2013321","DOI":"10.1249\/00005768-198105000-00008"},{"key":"2021120901591128900_R108","doi-asserted-by":"crossref","unstructured":"Tolfrey K, Campbell IG, Jones AM. Selected predictor variables and the lipid-lipoprotein profile of prepubertal girls and boys. Med Sci Sports Exerc.\u20081999;31:1550\u20131557","DOI":"10.1097\/00005768-199911000-00009"},{"key":"2021120901591128900_R109","doi-asserted-by":"crossref","unstructured":"Tonstad S, Leren TP, Sivertsen M, Ose L. Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol.\u20081995;15:1009\u20131014","DOI":"10.1161\/01.ATV.15.8.1009"},{"key":"2021120901591128900_R110","doi-asserted-by":"crossref","unstructured":"Twisk JW, Kemper HC, Van Mechelen W, Post GB. Clustering of risk factors for coronary heart disease: the longitudinal relationship with lifestyle. Ann Epidemiol.\u20082001;11:157\u2013165","DOI":"10.1016\/S1047-2797(00)00202-7"},{"key":"2021120901591128900_R111","doi-asserted-by":"crossref","unstructured":"Twisk JW, Kemper HC, van Mechelen W, Post GB, van Lenthe FJ. Body fatness: longitudinal relationship of body mass index and the sum of skinfolds with other risk factors for coronary heart disease. Int J Obes Relat Metab Disord.\u20081998;22:915\u2013922","DOI":"10.1038\/sj.ijo.0800695"},{"key":"2021120901591128900_R112","doi-asserted-by":"crossref","unstructured":"Twisk JW, Kemper HC, Mellenbergh GJ, van Mechelen W, Post GB. Relation between the longitudinal development of lipoprotein levels and lifestyle parameters during adolescence and young adulthood. Ann Epidemiol.\u20081996;6:246\u2013256","DOI":"10.1016\/1047-2797(96)00003-8"},{"key":"2021120901591128900_R113","doi-asserted-by":"crossref","unstructured":"van Lenthe FJ, van Mechelen W, Kemper HC, Twisk JW. Association of a central pattern of body fat with blood pressure and lipoproteins from adolescence into adulthood. The Amsterdam Growth and Health Study. Am J Epidemiol.\u20081998;147:686\u2013693","DOI":"10.1093\/oxfordjournals.aje.a009510"},{"key":"2021120901591128900_R114","doi-asserted-by":"crossref","unstructured":"van Stiphout WA, Hofman A, de Bruijn AM, Valkenburg HA. Distributions and determinants of total and high-density lipoprotein cholesterol in Dutch children and young adults. Prev Med.\u20081985;14:169\u2013180","DOI":"10.1016\/0091-7435(85)90032-5"},{"key":"2021120901591128900_R115","doi-asserted-by":"crossref","unstructured":"Ward SD, Melin JR, Lloyd FP, Norton JA Jr, Christian JC. Determinants of plasma cholesterol in children: a family study. Am J Clin Nutr.\u20081980;33:63\u201370","DOI":"10.1093\/ajcn\/33.1.63"},{"key":"2021120901591128900_R116","doi-asserted-by":"crossref","unstructured":"Wong ND, Hei TK, Qaqundah PY, Davidson DM, Bassin SL, Gold KV. Television viewing and pediatric hypercholesterolemia. Pediatrics.\u20081992;90:75\u201379","DOI":"10.1542\/peds.90.1.75"},{"key":"2021120901591128900_R117","doi-asserted-by":"crossref","unstructured":"Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch Intern Med.\u20081995;155:190\u2013196","DOI":"10.1001\/archinte.155.2.190"},{"key":"2021120901591128900_R118","doi-asserted-by":"crossref","unstructured":"Gliksman MD, Lazarus R, Wilson A. Differences in serum lipids in Australian children: is diet responsible?Int J Epidemiol.\u20081993;22:247\u2013254","DOI":"10.1093\/ije\/22.2.247"},{"key":"2021120901591128900_R119","doi-asserted-by":"crossref","unstructured":"Kunz F, Pechlaner C, Hortnagl H, Pfister R. The smoker's paradox and the real risk of smoking. Eur J Epidemiol.\u20082005;20:161\u2013167","DOI":"10.1007\/s10654-004-3004-x"},{"key":"2021120901591128900_R120","doi-asserted-by":"crossref","unstructured":"Berenson GS, Srinivasan S. Cholesterol as a risk factor for early atherosclerosis: the Bogalusa Heart Study. Prog Pediatr Cardiol.\u20082003;17:113\u2013122","DOI":"10.1016\/S1058-9813(03)00048-1"},{"key":"2021120901591128900_R121","doi-asserted-by":"crossref","unstructured":"Bachman RP, Schoen EJ, Stembridge A, Jurecki ER, Imagire RS. Compliance with childhood cholesterol screening among members of a prepaid health plan. Am J Dis Child.\u20081993;147:382\u2013385","DOI":"10.1001\/archpedi.1993.02160280032013"},{"key":"2021120901591128900_R122","doi-asserted-by":"crossref","unstructured":"Bistritzer T, Rosenzweig L, Barr J, et al. Lipid profile with paternal history of coronary heart disease before age 40. Arch Dis Child.\u20081995;73:62\u201365","DOI":"10.1136\/adc.73.1.62"},{"key":"2021120901591128900_R123","doi-asserted-by":"crossref","unstructured":"Davidson DM, Bradley BJ, Landry SM, Iftner CA, Bramblett SN. School-based blood cholesterol screening. J Pediatr Health Care.\u20081989;3:3\u20138","DOI":"10.1016\/0891-5245(89)90043-6"},{"key":"2021120901591128900_R124","doi-asserted-by":"crossref","unstructured":"Dennison BA, Jenkins PL, Pearson TA. Challenges to implementing the current pediatric cholesterol screening guidelines into practice. Pediatrics.\u20081994;94:296\u2013302","DOI":"10.1542\/peds.94.3.296"},{"key":"2021120901591128900_R125","doi-asserted-by":"crossref","unstructured":"Faigel HC. Screening college students for hypercholesterolemia. J Am Coll Health.\u20081992;40:272\u2013275","DOI":"10.1080\/07448481.1992.9936292"},{"key":"2021120901591128900_R126","unstructured":"Garcia RE, Moodie DS. Routine cholesterol surveillance in childhood. Pediatrics.\u20081989;84:751\u2013755"},{"key":"2021120901591128900_R127","doi-asserted-by":"crossref","unstructured":"Hammond J, Chinn S, Richardson H, Rona R. Response to venepuncture for monitoring in primary schools. Arch Dis Child.\u20081994;70:367\u2013369","DOI":"10.1136\/adc.70.5.367"},{"key":"2021120901591128900_R128","doi-asserted-by":"crossref","unstructured":"Heyden S, Schneider KA, Roberts KF. Effectiveness of education-screening on cholesterol levels of students. Ann Nutr Metab.\u20081991;35:71\u201376","DOI":"10.1159\/000177628"},{"key":"2021120901591128900_R129","unstructured":"Lansing AM, Barbie RN, Shaheen KA. Regional cholesterol screening: problems and potentials. J Ky Med Assoc.\u20081990;88:170\u2013174"},{"key":"2021120901591128900_R130","doi-asserted-by":"crossref","unstructured":"Manchester RA, McDuffie C, Diamond E. Screening for hypercholesterolemia in college students. J Am Coll Health.\u20081989;37:149\u2013153","DOI":"10.1080\/07448481.1989.9938407"},{"key":"2021120901591128900_R131","doi-asserted-by":"crossref","unstructured":"Polonsky SM, Bellet PS, Sprecher DL. Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment. Pediatrics.\u20081993;91:92\u201396","DOI":"10.1542\/peds.91.1.92"},{"key":"2021120901591128900_R132","doi-asserted-by":"crossref","unstructured":"Skovby F, Micic S, Jepsen B, et al. Screening for familial hypercholesterolaemia by measurement of apolipoproteins in capillary blood. Arch Dis Child.\u20081991;66:844\u2013847","DOI":"10.1136\/adc.66.7.844"},{"key":"2021120901591128900_R133","doi-asserted-by":"crossref","unstructured":"Sveger T, Flodmark CE, Nordborg K, Nilsson-Ehle P, Borgfors N. Hereditary dyslipidemias and combined risk factors in children with a family history of premature coronary artery disease. Arch Dis Child.\u20082000;82:292\u2013296","DOI":"10.1136\/adc.82.4.292"},{"key":"2021120901591128900_R134","doi-asserted-by":"crossref","unstructured":"Goff DC Jr, Donker GA, Ragan JD Jr, et al. Cholesterol screening in pediatric practice. Pediatrics.\u20081991;88:250\u2013258","DOI":"10.1542\/peds.88.2.250"},{"key":"2021120901591128900_R135","doi-asserted-by":"crossref","unstructured":"McHale SM, Tershakovec AM, Corneal DA, Tournier BA, Shannon BM. Psychosocial factors in nutrition education for hypercholesterolemic children. Ann Behav Med.\u20081998;20:233\u2013240","DOI":"10.1007\/BF02884966"},{"key":"2021120901591128900_R136","unstructured":"Rosenberg E, Lamping DL, Joseph L, Pless IB, Franco ED. Cholesterol screening of children at high risk: behavioural and psychological effects. CMAJ.\u20081997;156:489\u2013496"},{"key":"2021120901591128900_R137","doi-asserted-by":"crossref","unstructured":"Tonstad S. Familial hypercholesterolaemia: a pilot study of parents\u2019 and children's concerns. Acta Paediatr.\u20081996;85:1307\u20131313","DOI":"10.1111\/j.1651-2227.1996.tb13916.x"},{"key":"2021120901591128900_R138","doi-asserted-by":"crossref","unstructured":"Rosenthal SL, Knauer-Black S, Stahl MP, Catalanotto TJ, Sprecher DL. The psychological functioning of children with hypercholesterolemia and their families: a preliminary investigation. Clin Pediatr (Phila).\u20081993;32:135\u2013141","DOI":"10.1177\/000992289303200302"},{"key":"2021120901591128900_R139","doi-asserted-by":"crossref","unstructured":"Sinaiko AR, Prineas RJ. Reduction of cardiovascular disease: what is the role of the pediatrician?Pediatrics. 1998;102(5). Available at: www.pediatrics.org\/cgi\/content\/full\/102\/5\/e61","DOI":"10.1542\/peds.102.5.e61"},{"key":"2021120901591128900_R140","doi-asserted-by":"crossref","unstructured":"Nader PR, Yang M, Luepker RV, et al. Parent and physician response to children's cholesterol values of 200 mg\/dL or greater: the Child and Adolescent Trial for Cardiovascular Health Experiment. Pediatrics. 1997;99(5). Available at: www.pediatrics.org\/cgi\/content\/full\/99\/5\/e5","DOI":"10.1542\/peds.99.5.e5"},{"key":"2021120901591128900_R141","doi-asserted-by":"crossref","unstructured":"Bastida S, Perea S, Sanchez-Muniz FJ. Do neonates with high serum cholesterol levels have a different high density lipoprotein composition?Eur J Pediatr.\u20081998;157:66\u201370","DOI":"10.1007\/s004310050769"},{"key":"2021120901591128900_R142","doi-asserted-by":"crossref","unstructured":"Andersen GE, Lous P, Friis-Hansen B. Screening for hyperlipoproteinemia in 10,000 Danish newborns: follow-up studies in 522 children with elevated cord serum VLDL-LDL-cholesterol. Acta Paediatr Scand.\u20081979;68:541\u2013545","DOI":"10.1111\/j.1651-2227.1979.tb05052.x"},{"key":"2021120901591128900_R143","doi-asserted-by":"crossref","unstructured":"Kenny D, Ward OC, Mulhern B, Rashied AA. Failure of cord serum cholesterol and beta-lipoprotein as screening tests for familial hyperlipoproteinaemia. Ir J Med Sci.\u20081984;153:100\u2013105","DOI":"10.1007\/BF02942001"},{"key":"2021120901591128900_R144","doi-asserted-by":"crossref","unstructured":"Cress HR, Shaher RM, Greenberg MH, Laffin R. Lipoproteins in neonates. J Pediatr.\u20081974;84:585\u2013587","DOI":"10.1016\/S0022-3476(74)80686-4"},{"key":"2021120901591128900_R145","doi-asserted-by":"crossref","unstructured":"Barnes K, Nestel PJ, Pryke ES, Whyte HM. Neonatal plasma lipids. Med J Aust.\u20081972;2(18):1002\u20131005","DOI":"10.5694\/j.1326-5377.1972.tb103681.x"},{"key":"2021120901591128900_R146","doi-asserted-by":"crossref","unstructured":"Andersen GE, Brokhattingen K, Lous P. Familial hypobetalipoproteinaemia in 9 children diagnosed as the result of cord blood screening for hypolipoproteinaemia in 10 000 Danish newborns. Arch Dis Child.\u20081979;54:691\u2013694","DOI":"10.1136\/adc.54.9.691"},{"key":"2021120901591128900_R147","unstructured":"Goldstein JL, Albers JJ, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Plasma lipid levels and coronary heart disease in adult relatives of newborns with normal and elevated cord blood lipids. Am J Hum Genet.\u20081974;26:727\u2013735"},{"key":"2021120901591128900_R148","doi-asserted-by":"crossref","unstructured":"Darmady JM, Fosbrooke AS, Lloyd JK. Prospective study of serum cholesterol levels during first year of life. Br Med J.\u20081972;2(5815):685\u2013688","DOI":"10.1136\/bmj.2.5815.685"},{"key":"2021120901591128900_R149","doi-asserted-by":"crossref","unstructured":"Tsang RC, Fallat RW, Glueck CJ. Cholesterol at birth and age 1: comparison of normal and hypercholesterolemic neonates. Pediatrics.\u20081974;53:458\u2013470","DOI":"10.1542\/peds.53.4.458"},{"key":"2021120901591128900_R150","doi-asserted-by":"crossref","unstructured":"Kwiterovich PO Jr, Levy RI, Fredrickson DS. Neonatal diagnosis of familial type-II hyperlipoproteinaemia. Lancet.\u20081973;1(7795):118\u2013121","DOI":"10.1016\/S0140-6736(73)90194-3"},{"key":"2021120901591128900_R151","doi-asserted-by":"crossref","unstructured":"Andersen GE, Nielsen HG. Neonatal screening for hyperlipoproteinemia: methods for direct estimation of cord serum VLDL + LDL. Clin Chim Acta.\u20081976;66:29\u201341","DOI":"10.1016\/0009-8981(76)90368-5"},{"key":"2021120901591128900_R152","doi-asserted-by":"crossref","unstructured":"Van Biervliet JP, Vercaemst R, De Keersgieter W, Vinaimont N, Caster H, Rosseneu M. Evolution of lipoprotein patterns in newborns. Acta Paediatr Scand.\u20081980;69:593\u2013596","DOI":"10.1111\/j.1651-2227.1980.tb07327.x"},{"key":"2021120901591128900_R153","doi-asserted-by":"crossref","unstructured":"Brewster TG, Waite DJ, Hudson GA. Quantitation of beta-lipoprotein in cord serum by rate nephelometric immunoassay: a potential screening test for familial hypercholesterolemia. Clin Chem.\u20081982;28:1192\u20131196","DOI":"10.1093\/clinchem\/28.5.1192"},{"key":"2021120901591128900_R154","doi-asserted-by":"crossref","unstructured":"Wood WG, Schumacher M, Weigert S. (Apo)lipoprotein(a) concentrations at birth and in the first days and months of life: studies on the distribution of serum levels and the predictive value of measurements made at this time. Eur J Clin Chem Clin Biochem.\u20081995;33:139\u2013145","DOI":"10.1515\/cclm.1995.33.3.139"},{"key":"2021120901591128900_R155","doi-asserted-by":"crossref","unstructured":"Vladutiu GD, Glueck CJ, Schultz MT, McNeely S, Guthrie R. beta-Lipoprotein quantitation in cord blood spotted on filter paper: a screening test. Clin Chem.\u20081980;26:1285\u20131290","DOI":"10.1093\/clinchem\/26.9.1285"},{"key":"2021120901591128900_R156","doi-asserted-by":"crossref","unstructured":"Wilcken DE, Blades BL, Dudman NP. A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention. J Inherit Metab Dis.\u20081988;11(suppl 1):87\u201390","DOI":"10.1007\/BF01800573"},{"key":"2021120901591128900_R157","doi-asserted-by":"crossref","unstructured":"Blades BL, Dudman NP, Wilcken DE. Screening for familial hypercholesterolemia in 5000 neonates: a recall study. Pediatr Res.\u20081988;23:500\u2013504","DOI":"10.1203\/00006450-198805000-00013"},{"key":"2021120901591128900_R158","doi-asserted-by":"crossref","unstructured":"Bangert SK, Eldridge PH, Peters TJ. Neonatal screening for familial hypercholesterolaemia by immunoturbidimetric assay of apolipoprotein B in dried blood spots. Clin Chim Acta.\u20081992;213(1\u20133):95\u2013101","DOI":"10.1016\/0009-8981(92)90224-E"},{"key":"2021120901591128900_R159","doi-asserted-by":"crossref","unstructured":"Van Biervliet JP, Vinaimont N, Caster H, Rosseneu M, Belpaire F. A screening procedure for dyslipoproteinemia in the newborn: apoprotein quantitation on dried blood spots. Clin Chim Acta.\u20081982;120:191\u2013200","DOI":"10.1016\/0009-8981(82)90155-3"},{"key":"2021120901591128900_R160","unstructured":"Roseneu M, Van Biervliet JP. Screening and follow-up of infants with dyslipoproteinemia. Prog Clin Biol Res.\u20081985;188:79\u201386"},{"key":"2021120901591128900_R161","doi-asserted-by":"crossref","unstructured":"Beeso J, Wong N, Ayling R, et al. Screening for hypercholesterolaemia in 10,000 neonates in a multi-ethnic population. Eur J Pediatr.\u20081999;158:833\u2013837","DOI":"10.1007\/s004310051217"},{"key":"2021120901591128900_R162","doi-asserted-by":"crossref","unstructured":"Croyle RT, Sun YC, Louie DH. Psychological minimization of cholesterol test results: moderators of appraisal in college students and community residents. Health Psychol.\u20081993;12:503\u2013507","DOI":"10.1037\/0278-6133.12.6.503"},{"key":"2021120901591128900_R163","doi-asserted-by":"crossref","unstructured":"Epstein LH, Kuller LH, Wing RR, Valoski A, McCurley J. The effect of weight control on lipid changes in obese children. Am J Dis Child.\u20081989;143:454\u2013457","DOI":"10.1001\/archpedi.1989.02150160080016"},{"key":"2021120901591128900_R164","doi-asserted-by":"crossref","unstructured":"de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol.\u20082002;40:2117\u20132121","DOI":"10.1016\/S0735-1097(02)02593-7"},{"key":"2021120901591128900_R165","doi-asserted-by":"crossref","unstructured":"McCrindle BW, Helden E, Cullen-Dean G, Conner WT. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. Pediatr Res.\u20082002;51:715\u2013721","DOI":"10.1203\/00006450-200206000-00009"},{"key":"2021120901591128900_R166","doi-asserted-by":"crossref","unstructured":"de Jongh S, Vissers MN, Rol P, Bakker HD, Kastelein JJ, Stroes ES. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis.\u20082003;26:343\u2013351","DOI":"10.1023\/A:1025155002348"},{"key":"2021120901591128900_R167","doi-asserted-by":"crossref","unstructured":"Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res.\u20081995;36:1807\u20131812","DOI":"10.1016\/S0022-2275(20)41499-3"},{"key":"2021120901591128900_R168","doi-asserted-by":"crossref","unstructured":"McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr.\u20082003;143:74\u201380","DOI":"10.1016\/S0022-3476(03)00186-0"},{"key":"2021120901591128900_R169","doi-asserted-by":"crossref","unstructured":"Obarzanek E, Kimm SY, Barton BA, et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics.\u20082001;107:256\u2013264","DOI":"10.1542\/peds.107.2.256"},{"key":"2021120901591128900_R170","doi-asserted-by":"crossref","unstructured":"DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group. JAMA.\u20081995;273:1429\u20131435","DOI":"10.1001\/jama.273.18.1429"},{"key":"2021120901591128900_R171","doi-asserted-by":"crossref","unstructured":"Stein EA, Illingworth DR, Kwiterovich PO Jr, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA.\u20081999;281:137\u2013144","DOI":"10.1001\/jama.281.2.137"},{"key":"2021120901591128900_R172","doi-asserted-by":"crossref","unstructured":"Knipscheer HC, Boelen CC, Kastelein JJ, et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res.\u20081996;39:867\u2013871","DOI":"10.1203\/00006450-199605000-00021"},{"key":"2021120901591128900_R173","doi-asserted-by":"crossref","unstructured":"Shannon BM, Tershakovec AM, Martel JK, Achterberg CL, Cortner JA. Reduction of elevated LDL-cholesterol levels of 4- to 10-year-old children through home-based dietary education. Pediatrics.\u20081994;94:923\u2013927","DOI":"10.1542\/peds.94.6.923"},{"key":"2021120901591128900_R174","doi-asserted-by":"crossref","unstructured":"Becque MD, Katch VL, Rocchini AP, Marks CR, Moorehead C. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics.\u20081988;81:605\u2013612","DOI":"10.1542\/peds.81.5.605"},{"key":"2021120901591128900_R175","doi-asserted-by":"crossref","unstructured":"McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr.\u20081997;130:266\u2013273","DOI":"10.1016\/S0022-3476(97)70353-6"},{"key":"2021120901591128900_R176","doi-asserted-by":"crossref","unstructured":"Walter HJ, Hofman A, Connelly PA, Barrett LT, Kost KL. Primary prevention of chronic disease in childhood: changes in risk factors after one year of intervention. Am J Epidemiol.\u20081985;122:772\u2013781","DOI":"10.1093\/oxfordjournals.aje.a114160"},{"key":"2021120901591128900_R177","doi-asserted-by":"crossref","unstructured":"Amundsen AL, Ose L, Nenseter MS, Ntanios FY. Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr.\u20082002;76:338\u2013344","DOI":"10.1093\/ajcn\/76.2.338"},{"key":"2021120901591128900_R178","doi-asserted-by":"crossref","unstructured":"Couture P, Brun LD, Szots F, et al. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol.\u20081998;18:1007\u20131012","DOI":"10.1161\/01.ATV.18.6.1007"},{"key":"2021120901591128900_R179","doi-asserted-by":"crossref","unstructured":"Davidson MH, Dugan LD, Burns JH, Sugimoto D, Story K, Drennan K. A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study. Am J Clin Nutr.\u20081996;63:96\u2013102","DOI":"10.1093\/ajcn\/63.1.96"},{"key":"2021120901591128900_R180","doi-asserted-by":"crossref","unstructured":"Dennison BA, Levine DM. Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia. J Pediatr.\u20081993;123:24\u201329","DOI":"10.1016\/S0022-3476(05)81532-X"},{"key":"2021120901591128900_R181","doi-asserted-by":"crossref","unstructured":"Engler MM, Engler MB, Malloy MJ, et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk From Lipids in Youth (EARLY) Trial. Circulation.\u20082003;108:1059\u20131063","DOI":"10.1161\/01.CIR.0000086345.09861.A0"},{"key":"2021120901591128900_R182","doi-asserted-by":"crossref","unstructured":"Ferguson MA, Gutin B, Le NA, et al. Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int J Obes Relat Metab Disord.\u20081999;23:889\u2013895","DOI":"10.1038\/sj.ijo.0800968"},{"key":"2021120901591128900_R183","doi-asserted-by":"crossref","unstructured":"Lambert M, Lupien PJ, Gagne C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics.\u20081996;97:619\u2013628","DOI":"10.1542\/peds.97.5.619"},{"key":"2021120901591128900_R184","doi-asserted-by":"crossref","unstructured":"Malloy MJ, Kane JP, Rowe JS. Familial hypercholesterolemia in children: treatment with p-aminosalicylic acid. Pediatrics.\u20081978;61:365\u2013372","DOI":"10.1542\/peds.61.3.365"},{"key":"2021120901591128900_R185","doi-asserted-by":"crossref","unstructured":"Tonstad S, Sivertsen M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child.\u20081996;74:157\u2013160","DOI":"10.1136\/adc.74.2.157"},{"key":"2021120901591128900_R186","doi-asserted-by":"crossref","unstructured":"Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr.\u20081996;129:42\u201349","DOI":"10.1016\/S0022-3476(96)70188-9"},{"key":"2021120901591128900_R187","doi-asserted-by":"crossref","unstructured":"de Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation.\u20082002;106:2231\u20132237","DOI":"10.1161\/01.CIR.0000035247.42888.82"},{"key":"2021120901591128900_R188","doi-asserted-by":"crossref","unstructured":"Kang HS, Gutin B, Barbeau P, et al. Physical training improves insulin resistance syndrome markers in obese adolescents. Med Sci Sports Exerc.\u20082002;34:1920\u20131927","DOI":"10.1097\/00005768-200212000-00010"},{"key":"2021120901591128900_R189","doi-asserted-by":"crossref","unstructured":"Kuehl KS, Cockerham JT, Hitchings M, Slater D, Nixon G, Rifai N. Effective control of hypercholesterolemia in children with dietary interventions based in pediatric practice. Prev Med.\u20081993;22:154\u2013166","DOI":"10.1006\/pmed.1993.1013"},{"key":"2021120901591128900_R190","doi-asserted-by":"crossref","unstructured":"Stallings VA, Cortner JA, Shannon BM, et al. Preliminary report of a home-based education program for dietary treatment of hypercholesterolemia in children. Am J Health Promot.\u20081993;8:106\u2013108","DOI":"10.4278\/0890-1171-8.2.106"},{"key":"2021120901591128900_R191","doi-asserted-by":"crossref","unstructured":"Stergioulas A, Tripolitsioti A, Messinis D, Bouloukos A, Nounopoulos C. The effects of endurance training on selected coronary risk factors in children. Acta Paediatr.\u20081998;87:401\u2013404","DOI":"10.1111\/j.1651-2227.1998.tb01467.x"},{"key":"2021120901591128900_R192","doi-asserted-by":"crossref","unstructured":"Wheeler KA, West RJ, Lloyd JK, Barley J. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child.\u20081985;60:34\u201337","DOI":"10.1136\/adc.60.1.34"},{"key":"2021120901591128900_R193","doi-asserted-by":"crossref","unstructured":"Williams CL, Bollella M, Spark A, Puder D. Soluble fiber enhances the hypocholesterolemic effect of the step I diet in childhood. J Am Coll Nutr.\u20081995;14:251\u2013257","DOI":"10.1080\/07315724.1995.10718504"},{"key":"2021120901591128900_R194","doi-asserted-by":"crossref","unstructured":"Boreham CA, Wallace WF, Nevill A. Training effects of accumulated daily stair-climbing exercise in previously sedentary young women. Prev Med.\u20082000;30:277\u2013281","DOI":"10.1006\/pmed.2000.0634"},{"key":"2021120901591128900_R195","doi-asserted-by":"crossref","unstructured":"Gold K, Wong N, Tong A, et al. Serum apolipoprotein and lipid profile effects of an oat-bran-supplemented, low-fat diet in children with elevated serum cholesterol. Ann N Y Acad Sci.\u20081991;623:429\u2013431","DOI":"10.1111\/j.1749-6632.1991.tb43758.x"},{"key":"2021120901591128900_R196","doi-asserted-by":"crossref","unstructured":"Linder CW, DuRant RH, Mahoney OM. The effect of physical conditioning on serum lipids and lipoproteins in white male adolescents. Med Sci Sports Exerc.\u20081983;15:232\u2013236","DOI":"10.1249\/00005768-198315030-00009"},{"key":"2021120901591128900_R197","doi-asserted-by":"crossref","unstructured":"Savage MP, Petratis MM, Thomson WH, Berg K, Smith JL, Sady SP. Exercise training effects on serum lipids of prepubescent boys and adult men. Med Sci Sports Exerc.\u20081986;18:197\u2013204","DOI":"10.1249\/00005768-198604000-00009"},{"key":"2021120901591128900_R198","doi-asserted-by":"crossref","unstructured":"Engler MM, Engler MB, Malloy M, et al. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther.\u20082004;42:672\u2013679","DOI":"10.5414\/CPP42672"},{"key":"2021120901591128900_R199","doi-asserted-by":"crossref","unstructured":"McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med.\u20081998;152:1089\u20131094","DOI":"10.1001\/archpedi.152.11.1089"},{"key":"2021120901591128900_R200","doi-asserted-by":"crossref","unstructured":"Engler MM, Engler MB, Malloy MJ, Paul SM, Kulkarni KR, Mietus-Snyder ML. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol.\u20082005;95:869\u2013871","DOI":"10.1016\/j.amjcard.2004.12.014"},{"key":"2021120901591128900_R201","doi-asserted-by":"crossref","unstructured":"Fernandes J, Dijkhuis-Stoffelsma R, Groot PH, Grose WF, Ambagtsheer JJ. The effect of a virtually cholesterol-free, high-linoleic-acid vegetarian diet on serum lipoproteins of children with familial hypercholesterolemia (type II-A). Acta Paediatr Scand.\u20081981;70:677\u2013682","DOI":"10.1111\/j.1651-2227.1981.tb05767.x"},{"key":"2021120901591128900_R202","doi-asserted-by":"crossref","unstructured":"Hedman M, Neuvonen PJ, Neuvonen M, Antikainen M. Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia. Clin Pharmacol Ther.\u20082003;74:178\u2013185","DOI":"10.1016\/S0009-9236(03)00153-X"},{"key":"2021120901591128900_R203","doi-asserted-by":"crossref","unstructured":"Dirisamer A, Hachemian N, Bucek RA, Wolf F, Reiter M, Widhalm K. The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr.\u20082003;162:421\u2013425","DOI":"10.1007\/s00431-003-1181-3"},{"key":"2021120901591128900_R204","doi-asserted-by":"crossref","unstructured":"Sinzinger H, O'Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol.\u20082004;57:525\u2013528","DOI":"10.1111\/j.1365-2125.2003.02044.x"},{"key":"2021120901591128900_R205","doi-asserted-by":"crossref","unstructured":"de Jongh S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HS, Last BF. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr.\u20082003;92:1096\u20131101","DOI":"10.1111\/j.1651-2227.2003.tb02584.x"},{"key":"2021120901591128900_R206","doi-asserted-by":"crossref","unstructured":"Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children. Lancet.\u20081992;339:1488","DOI":"10.1016\/0140-6736(92)92092-T"},{"key":"2021120901591128900_R207","unstructured":"Stefanutti C, Lucani G, Vivenzio A, Di Giacomo S. Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood. Drugs Exp Clin Res.\u20081999;25:23\u201328"},{"key":"2021120901591128900_R208","doi-asserted-by":"crossref","unstructured":"Curtis DM, Driscoll DJ, Goldman DH, Weidman WH. Loss of dental enamel in a patient taking cholestyramine. Mayo Clin Proc.\u20081991;66:1131","DOI":"10.1016\/S0025-6196(12)65794-2"},{"key":"2021120901591128900_R209","doi-asserted-by":"crossref","unstructured":"Farah JR, Kwiterovich PO, Neill CA. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia. Adv Exp Med Biol.\u20081977;82:212\u2013215","DOI":"10.1007\/978-1-4613-4220-5_42"},{"key":"2021120901591128900_R210","doi-asserted-by":"crossref","unstructured":"Farah JR, Kwiterovich PO Jr, Neill CA. Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia. Lancet.\u20081977;1(8002):59\u201363","DOI":"10.1016\/S0140-6736(77)91078-9"},{"key":"2021120901591128900_R211","doi-asserted-by":"crossref","unstructured":"Groot PH, Dijkhuis-Stoffelsma R, Grose WF, Ambagtsheer JJ, Fernandes J. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia. Acta Paediatr Scand.\u20081983;72:81\u201385","DOI":"10.1111\/j.1651-2227.1983.tb09668.x"},{"key":"2021120901591128900_R212","doi-asserted-by":"crossref","unstructured":"Hansen D, Michaelsen KF, Skovby F. Growth during treatment of familial hypercholesterolemia. Acta Paediatr.\u20081992;81:1023\u20131025","DOI":"10.1111\/j.1651-2227.1992.tb12167.x"},{"key":"2021120901591128900_R213","doi-asserted-by":"crossref","unstructured":"Harvengt C, Desager JP. Colestipol in familial type II hyperlipoproteinemia: a three-year trial. Clin Pharmacol Ther.\u20081976;20:310\u2013314","DOI":"10.1002\/cpt1976203310"},{"key":"2021120901591128900_R214","doi-asserted-by":"crossref","unstructured":"Koletzko B, Kupke I, Wendel U. Treatment of hypercholesterolemia in children and adolescents. Acta Paediatr.\u20081992;81:682\u2013685","DOI":"10.1111\/j.1651-2227.1992.tb12333.x"},{"key":"2021120901591128900_R215","doi-asserted-by":"crossref","unstructured":"Liacouras CA, Coates PM, Gallagher PR, Cortner JA. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. J Pediatr.\u20081993;122:477\u2013482","DOI":"10.1016\/S0022-3476(05)83444-4"},{"key":"2021120901591128900_R216","doi-asserted-by":"crossref","unstructured":"Schwarz KB, Goldstein PD, Witztum JL, Schonfeld G. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol. Pediatrics.\u20081980;65:243\u2013250","DOI":"10.1542\/peds.65.2.243"},{"key":"2021120901591128900_R217","doi-asserted-by":"crossref","unstructured":"Tonstad S, Ose L. Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta Paediatr.\u20081996;85:1080\u20131082","DOI":"10.1111\/j.1651-2227.1996.tb14221.x"},{"key":"2021120901591128900_R218","doi-asserted-by":"crossref","unstructured":"Tonstad S, Refsum H, Ose L, Ueland PM. The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. J Pediatr.\u20081998;132:365\u2013368","DOI":"10.1016\/S0022-3476(98)70465-2"},{"key":"2021120901591128900_R219","doi-asserted-by":"crossref","unstructured":"West RJ, Lloyd JK. Use of cholestyramine in treatment of children with familial hypercholesterolaemia. Arch Dis Child.\u20081973;48:370\u2013374","DOI":"10.1136\/adc.48.5.370"},{"key":"2021120901591128900_R220","doi-asserted-by":"crossref","unstructured":"West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut.\u20081975;16:93\u201398","DOI":"10.1136\/gut.16.2.93"},{"key":"2021120901591128900_R221","unstructured":"West RJ, Fosbrooke AS, Lloyd JK. Treatment of children with familial hypercholesterolaemia. Postgrad Med J.\u20081975;51(8 suppl):82\u201387"},{"key":"2021120901591128900_R222","doi-asserted-by":"crossref","unstructured":"West RJ, Lloyd JK, Leonard JV. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine. Lancet.\u20081980;2(8200):873\u2013875","DOI":"10.1016\/S0140-6736(80)92044-9"},{"key":"2021120901591128900_R223","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Tsang RC, Fallat RW, Mellies M. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months. Pediatrics.\u20081977;59:433\u2013441","DOI":"10.1542\/peds.59.3.433"},{"key":"2021120901591128900_R224","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Mellies MJ, Dine M, Perry T, Laskarzewski P. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia [published retraction appears in Glueck CJ, Laskarzewski P, Meelies MJ, Perry T. Pediatrics. 1987;80:766]. Pediatrics.\u20081986;78:338\u2013348","DOI":"10.1542\/peds.78.2.338"},{"key":"2021120901591128900_R225","unstructured":"Glueck CJ, Tsang RC, Fallat RW, Scheel D. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin. Pediatrics.\u20081974;54:51\u201355"},{"key":"2021120901591128900_R226","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Fallat R, Tsang R. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin. Pediatrics.\u20081973;52:669\u2013679","DOI":"10.1542\/peds.52.5.669"},{"key":"2021120901591128900_R227","doi-asserted-by":"crossref","unstructured":"Becker M, Staab D, Von Bergman K. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. Pediatrics.\u20081992;89:138\u2013142","DOI":"10.1542\/peds.89.1.138"},{"key":"2021120901591128900_R228","doi-asserted-by":"crossref","unstructured":"Colletti RB, Neufeld EJ, Roff NK, McAuliffe TL, Baker AL, Newburger JW. Niacin treatment of hypercholesterolemia in children. Pediatrics.\u20081993;92:78\u201382","DOI":"10.1542\/peds.92.1.78"},{"key":"2021120901591128900_R229","doi-asserted-by":"crossref","unstructured":"McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res.\u20082002;10:642\u2013650","DOI":"10.1038\/oby.2002.87"},{"key":"2021120901591128900_R230","unstructured":"Stein EA. Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis.\u20081989;9(1 suppl):I145\u2013I151"},{"key":"2021120901591128900_R231","doi-asserted-by":"crossref","unstructured":"Steinmetz J, Morin C, Panek E, Siest G, Drouin P. Biological variations in hyperlipidemic children and adolescents treated with fenofibrate. Clin Chim Acta.\u20081981;112:43\u201353","DOI":"10.1016\/0009-8981(81)90267-9"},{"key":"2021120901591128900_R232","doi-asserted-by":"crossref","unstructured":"Copperman N, Schebendach J, Arden MR, Jacobson MS. Nutrient quality of fat- and cholesterol-modified diets of children with hyperlipidemia. Arch Pediatr Adolesc Med.\u20081995;149:333\u2013336","DOI":"10.1001\/archpedi.1995.02170150113022"},{"key":"2021120901591128900_R233","doi-asserted-by":"crossref","unstructured":"Tonstad S, Novik TS, Vandvik IH. Psychosocial function during treatment for familial hypercholesterolemia. Pediatrics.\u20081996;98:249\u2013255","DOI":"10.1542\/peds.98.2.249"},{"key":"2021120901591128900_R234","doi-asserted-by":"crossref","unstructured":"Segall MM, Tamir I, Fosbrooke AS, Lloyd JK, Wolff OH. Effects of short-term high-carbohydrate feeding on serum triglyceride of children with familial hypercholesterolaemia. Arch Dis Child.\u20081970;45:393\u2013398","DOI":"10.1136\/adc.45.241.393"},{"key":"2021120901591128900_R235","doi-asserted-by":"crossref","unstructured":"Witschi JC, Singer M, Wu-Lee M, Stare FJ. Family cooperation and effectiveness in a cholesterol-lowering diet. J Am Diet Assoc.\u20081978;72:384\u2013389","DOI":"10.1016\/S0002-8223(21)06005-3"},{"key":"2021120901591128900_R236","doi-asserted-by":"crossref","unstructured":"McKenzie J, Dixon LB, Smiciklas-Wright H, Mitchell D, Shannon B, Tershakovec A. Change in nutrient intakes, number of servings, and contributions of total fat from food groups in 4- to 10-year-old children enrolled in a nutrition education study. J Am Diet Assoc.\u20081996;96:865\u2013873","DOI":"10.1016\/S0002-8223(96)00238-6"},{"key":"2021120901591128900_R237","doi-asserted-by":"crossref","unstructured":"Moreno LA, Sarria A, Lazaro A, Lasierra MP, Larrad L, Bueno M. Lymphocyte T subset counts in children with hypercholesterolemia receiving dietary therapy. Ann Nutr Metab.\u20081998;42:261\u2013265","DOI":"10.1159\/000012742"},{"key":"2021120901591128900_R238","doi-asserted-by":"crossref","unstructured":"Sa\u0301nchez-Bayle M, Gonzalez-Requejo A, Baeza J, et al. Diet therapy for hypercholesterolemia in children and adolescents: a follow-up. Arch Pediatr Adolesc Med.\u20081994;148:28\u201332","DOI":"10.1001\/archpedi.1994.02170010030006"},{"key":"2021120901591128900_R239","unstructured":"Rose V, Allen DM, Pearse RG, Chapell J. Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis. Can Med Assoc J.\u20081976;115:753\u2013756, 779"},{"key":"2021120901591128900_R240","doi-asserted-by":"crossref","unstructured":"Lifshitz F, Moses N. Growth failure: a complication of dietary treatment of hypercholesterolemia. Am J Dis Child.\u20081989;143:537\u2013542","DOI":"10.1001\/archpedi.1989.02150170035015"},{"key":"2021120901591128900_R241","doi-asserted-by":"crossref","unstructured":"Cetta F, Driscoll DJ, Lucas AR, et al. Growth patterns of hyperlipidemic children enrolled in a preventive cardiovascular health clinic. Clin Pediatr (Phila).\u20081994;33:588\u2013592","DOI":"10.1177\/000992289403301003"},{"key":"2021120901591128900_R242","doi-asserted-by":"crossref","unstructured":"Jacobson MS, Tomopoulos S, Williams CL, Arden MR, Deckelbaum RJ, Starc TJ. Normal growth in high-risk hyperlipidemic children and adolescents with dietary intervention. Prev Med.\u20081998;27:775\u2013780","DOI":"10.1006\/pmed.1998.0356"},{"key":"2021120901591128900_R243","doi-asserted-by":"crossref","unstructured":"Lavigne JV, Brown KM, Gidding S, et al. A cholesterol-lowering diet does not produce adverse psychological effects in children: three-year results from the dietary intervention study in children. Health Psychol.\u20081999;18:604\u2013613","DOI":"10.1037\/0278-6133.18.6.604"},{"key":"2021120901591128900_R244","doi-asserted-by":"crossref","unstructured":"Feoli-Fonseca JC, Levy E, Godard M, Lambert M. Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr.\u20081998;133:417\u2013423","DOI":"10.1016\/S0022-3476(98)70280-X"},{"key":"2021120901591128900_R245","doi-asserted-by":"crossref","unstructured":"Sa\u0301nchez-Bayle M, Soriano-Guillen L. Influence of dietary intervention on growth in children with hypercholesterolaemia. Acta Paediatr.\u20082003;92:1043\u20131046","DOI":"10.1111\/j.1651-2227.2003.tb02574.x"},{"key":"2021120901591128900_R246","doi-asserted-by":"crossref","unstructured":"Tershakovec AM, Jawad AF, Stallings VA, et al. Growth of hypercholesterolemic children completing physician-initiated low-fat dietary intervention. J Pediatr.\u20081998;133:28\u201334","DOI":"10.1016\/S0022-3476(98)70173-8"},{"key":"2021120901591128900_R247","doi-asserted-by":"crossref","unstructured":"Kaistha A, Deckelbaum RJ, Starc TJ, Couch SC. Overrestriction of dietary fat intake before formal nutritional counseling in children with hyperlipidemia. Arch Pediatr Adolesc Med.\u20082001;155:1225\u20131230","DOI":"10.1001\/archpedi.155.11.1225"},{"key":"2021120901591128900_R248","doi-asserted-by":"crossref","unstructured":"Pugliese MT, Weyman-Daum M, Moses N, Lifshitz F. Parental health beliefs: a cause of non-organic failure to thrive. Pediatrics.\u20081987;80:175\u2013181","DOI":"10.1542\/peds.80.2.175"},{"key":"2021120901591128900_R249","doi-asserted-by":"crossref","unstructured":"Amundsen AL, Ntanios F, Put N, Ose L. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur J Clin Nutr.\u20082004;58:1612\u20131620","DOI":"10.1038\/sj.ejcn.1602015"},{"key":"2021120901591128900_R250","doi-asserted-by":"crossref","unstructured":"Becker M, Staab D, Von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr.\u20081993;122:292\u2013296","DOI":"10.1016\/S0022-3476(06)80136-8"},{"key":"2021120901591128900_R251","doi-asserted-by":"crossref","unstructured":"Clarke JT, Cullen-Dean G, Regelink E, Chan L, Rose V. Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil. J Pediatr.\u20081990;116:139\u2013141","DOI":"10.1016\/S0022-3476(05)81666-X"},{"key":"2021120901591128900_R252","doi-asserted-by":"crossref","unstructured":"Glassman M, Spark A, Berezin S, Schwartz S, Medow M, Newman LJ. Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation. Am J Dis Child.\u20081990;144:973\u2013976","DOI":"10.1001\/archpedi.1990.02150330033016"},{"key":"2021120901591128900_R253","doi-asserted-by":"crossref","unstructured":"Gulesserian T, Widhalm K. Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia. J Am Coll Nutr.\u20082002;21:103\u2013108","DOI":"10.1080\/07315724.2002.10719201"},{"key":"2021120901591128900_R254","doi-asserted-by":"crossref","unstructured":"Mietus-Snyder M, Malloy MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. J Pediatr.\u20081998;133:35\u201340","DOI":"10.1016\/S0022-3476(98)70174-X"},{"key":"2021120901591128900_R255","doi-asserted-by":"crossref","unstructured":"Sa\u0301nchez-Bayle M, Gonzalez-Requejo A, Asensio-Anton J, Ruiz-Jarabo C, Fernandez-Ruiz ML, Baeza J. The effect of fiber supplementation on lipid profile in children with hypercholesterolemia. Clin Pediatr (Phila).\u20082001;40:291\u2013294","DOI":"10.1177\/000992280104000511"},{"key":"2021120901591128900_R256","doi-asserted-by":"crossref","unstructured":"Laurin D, Jacques H, Moorjani S, et al. Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia. Am J Clin Nutr.\u20081991;54:98\u2013103","DOI":"10.1093\/ajcn\/54.1.98"},{"key":"2021120901591128900_R257","doi-asserted-by":"crossref","unstructured":"Schlierf G, Oster P, Heuck CC, Raetzer H, Schellenberg B. Sitosterol in juvenile type II hyperlipoproteinemia. Atherosclerosis.\u20081978;30:245\u2013248","DOI":"10.1016\/0021-9150(78)90116-8"},{"key":"2021120901591128900_R258","doi-asserted-by":"crossref","unstructured":"Zavoral JH, Hannan P, Fields DJ, et al. The hypolipidemic effect of locust bean gum food products in familial hypercholesterolemic adults and children. Am J Clin Nutr.\u20081983;38:285\u2013294","DOI":"10.1093\/ajcn\/38.2.285"},{"key":"2021120901591128900_R259","doi-asserted-by":"crossref","unstructured":"Tolfrey K, Campbell IG, Batterham AM. Exercise training induced alterations in prepubertal children's lipid-lipoprotein profile. Med Sci Sports Exerc.\u20081998;30:1684\u20131692","DOI":"10.1097\/00005768-199812000-00005"},{"key":"2021120901591128900_R260","doi-asserted-by":"crossref","unstructured":"Kavey RE, Kveselis DA, Gaum WE. Valvular and pediatric congenital heart disease: exaggerated blood pressure response to exercise in children with increased low-density lipoprotein cholesterol. Am Heart J.\u20081997;133:162\u2013168","DOI":"10.1016\/S0002-8703(97)70204-7"},{"key":"2021120901591128900_R261","doi-asserted-by":"crossref","unstructured":"Barter PF, Ballantyne C, Carmena R, et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel. J Intern Med.\u20082006;259:247\u2013258","DOI":"10.1111\/j.1365-2796.2006.01616.x"},{"key":"2021120901591128900_R262","doi-asserted-by":"crossref","unstructured":"Chan DC, Watts GF. Apolipoproteins as markers and managers of coronary risk [published correction appears in QJM. 2006;99:807]. QJM.\u20082006;99:277\u2013287","DOI":"10.1093\/qjmed\/hcl027"},{"key":"2021120901591128900_R263","doi-asserted-by":"crossref","unstructured":"Iannuzzi A, Licenziati MR, Acampora C, et al. Increased carotid intima-media thickness and stiffness in obese children. Diabetes Care.\u20082004;27:2506\u20132508","DOI":"10.2337\/diacare.27.10.2506"},{"key":"2021120901591128900_R264","doi-asserted-by":"crossref","unstructured":"Wiegman A, de Groot E, Hutten BA. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet.\u20082004;363:369\u2013370","DOI":"10.1016\/S0140-6736(04)15467-6"},{"key":"2021120901591128900_R265","doi-asserted-by":"crossref","unstructured":"Ja\u0308rvisalo MJ, Lehtimaki T, Raitakari O. Determinants of arterial nitrate-mediated dilation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation.\u20082004;109:2885\u20132889","DOI":"10.1161\/01.CIR.0000129304.98566.D8"},{"key":"2021120901591128900_R266","doi-asserted-by":"crossref","unstructured":"Rodenburg J, Vissers MN, Wiegman A, Trip MD, Bakker HD, Kastelein JJ. Familial hypercholesterolemia in children. Curr Opin Lipidol.\u20082004;15:405\u2013411","DOI":"10.1097\/01.mol.0000137228.92396.f3"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/1\/e189\/1119850\/zpe0070700e189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/1\/e189\/1119850\/zpe0070700e189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T16:30:52Z","timestamp":1683909052000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/1\/e189\/70555\/Screening-and-Treatment-for-Lipid-Disorders-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,1]]},"references-count":266,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,7,1]]},"published-print":{"date-parts":[[2007,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-1801","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,1]]}}}